Biotechnology and bioprocessing continue to advance as novel therapies emerge for the treatment of a variety of diseases. In response to new molecular modalities and novel molecular entities, development and manufacturing approaches are evolving to meet the challenges associated with reliably and efficiently producing and supplying these products to enable patient access globally. The 2016 PDA Annual Meeting is the most significant conference to attend to gain the newest and most comprehensive information about innovative biopharmaceutical approaches and the bioprocessing technologies and manufacturing sciences being applied for development and commercialization.
The three main tracks of the meeting, “Advances in Bioprocess Development," “Innovation in Manufacturing Sciences,” and “Lifecycle Management and Continuous Improvement” will address many of the current challenges facing industry. Plenary sessions are focused on novel biopharmaceutical therapies, rapid product development approaches and manufacturing considerations. The program, which also includes breakfast and interest group sessions, is designed to offer science, innovation and technology information in a format that allows participants to gain a broad perspective on key topics as well as the opportunity to select the areas that are of most importance to them.
We will hear from experts involved in discovering novel therapies, rapid product development, bioprocess advances, manufacturing sciences, control strategies, regulatory submission and lifecycle management planning along with many other important topics. The 2016 PDA Annual Meeting is the most inclusive event, which provides insight into current and future trends in bioprocessing and manufacturing, providing participants the information they will need to prepare for the next wave of biopharmaceutical innovation. The PDA Annual Meeting also offers abundant networking opportunities for peer to peer discussion during the breaks and social events.
Please be sure and mark your calendar now so you don’t miss this exceptional information and networking opportunity.
Describe current trends in upstream and downstream process development and assess utility of future technology applications in pharmaceutical and biopharmaceutical processing
Summarize manufacturing needs required to process and supply novel cell therapies and personalized medicines
Explain approaches to mitigate supply chain risks for biopharmaceuticals and cell therapies and define effective strategies for implementation
Describe practical solutions for using analytical control systems, product and process monitoring information to successfully drive continuous improvement over the product lifecycle
Interpret the current issues with microbiological and adventitious agent control strategies and identify strategies to mitigate risks
Identify best practices for successful technology transfers and application of data to support process validation
Explain approaches to increase global access to medicines and describe industry response strategies to worldwide health crises like Ebola
Who Should Attend
Executive and Mid-Level Management
The 2016 PDA Annual Meeting will provide your company with the premier opportunity to gain access to and network with hundreds of key decision makers from the biopharmaceutical science and manufacturing industry. Become a sponsor of and/or exhibit at the 2016 PDA Annual Meeting to connect with industry thought leaders, strengthen your brand image, showcase your technology, launch new products, and show your company’s strong commitment to the industry.
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its nearly 10,000 members worldwide.